Available Technology

Oligonucleotide Treatment of Hearing Loss

The present invention provides methods of treating an auditory impairment associated with outer hair cells of the cochlea in a subject. The method may comprise administering to said subject an effective amount of a composition comprising, as an active agent, an oligonucleotide sequence having a portion of a mammalian telomere sequence so as to reduce the auditory impairment thereby treating the auditory impairment in the subject.

Patent Number: 
US10124062
Internal Laboratory Ref #: 
14-174
Patent Status: 
Issued
Patent Issue Date: 
November 13, 2018
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin